Drugs / Donor CD34+ cells
last change Oct 2015 re-read 2 minutes ago

Donor CD34+ cells

Developed for
systemic lupus erythematosus
Investigated by
City of Hope National Medical Center · National Heart, Lung, and Blood Institute (NHLBI) · Stanford University

Trials 1 · a red edge is where a trial was stopped

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00325741 Jun 2004 → Oct 2015 systemic lupus erythematosus Stanford University Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Donor CD34+ cells “one single infusion of donor CD34+ cells plus selected T cell add back on completion of TLI (day 0)” NCT00325741